Clinical trials
Completed Phase 3 Mental Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 8 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 14 |
| National Center for Research Resources (NCRR) | 9 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 6 |
| H. Lundbeck A/S | 4 |
| Merck Sharp & Dohme LLC | 4 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 4 |
| Forest Laboratories | 3 |
| AstraZeneca | 2 |
| Iris Sommer | 2 |
| New York State Psychiatric Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mental Disorders | 71 |
| Schizophrenia | 16 |
| Neurologic Manifestations | 14 |
| Rare Diseases | 13 |
| Major Depressive Disorder | 11 |
| Psychotic Disorders | 11 |
| Dementia | 9 |
| Mood Disorders | 9 |
| Depressive Disorder | 8 |
| Nervous System Diseases | 8 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.